The RT-PCR results showed that the mesenchymal marker (Vimentin) and transcription factor (Snail) were upregulated and epithelial marker (E-cadherin) was downregulated in hypoxia-treatment ovarian cancer cells (Fig. 3B–G). This evidence concerns the gene CDH1 and ovarian cancer.